Clinical trial
Phase III Randomized Controlled Study of Morphine and Nortriptyline in the…
NCT00004390 · National Center for Research Resources (NCRR), NIH · Completed
Key facts
| NCT number | NCT00004390 |
|---|---|
| Title | Phase III Randomized Controlled Study of Morphine and Nortriptyline in the Management of Postherpetic Neuralgia |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH Johns Hopkins University |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pain, Herpes Zoster |
| Intervention type | Drug |
| Interventions | desipramine, methadone, morphine, nortriptyline |
| Enrollment | 120 |
| Start date | Feb 1, 1995 |
| First posted | Oct 19, 1999 |
| Last update posted | Jun 24, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: